HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ISPH: Inspire Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
INSPIRE PHARMACEUTICALS INC (NASD)
ISPH 5.23 0.19 (3.77%) Vol.  233,006 16.00 CST

Nov 19, 2009 Global Market Perspective Review on JRCC, HLCS, ISPH, CHIP, GENZ andDSCO From TheFortuneFinancial.com
Nov 12, 2009 INSV: CEO Comments on Improved Q3 Results and Opportunities for Product Pipeline
Nov 09, 2009 Zacks Bull and Bear of the Day Highlights: Inspire Pharmaceuticals, Inc., Sears Holdings, Moody's Corp., CBS Corporation and Forest Oil Corporation
Nov 09, 2009 Inspire Pharmaceuticals, Inc. (ISPH)
Nov 09, 2009 ENR, MAC, ISPH, GOLD, JOYG and HLCS Receives Analytical Coverage fromWallStSense.com
Nov 09, 2009 Inspire Reports Third Quarter 2009 Financial Results
Nov 05, 2009 Inspire Reports Third Quarter 2009 Financial Results
Nov 05, 2009 Conference Calls Today: 10-10:30 A.M. EDT
Nov 04, 2009 Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
Oct 27, 2009 Groundbreaking Leadership Roundtable Draws Top CEOs
Oct 22, 2009 Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results
Oct 20, 2009 xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 20, 2009 : ISPH, ILMN, ACAD and BANF
Oct 20, 2009 Inspire's President and CEO Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award
Oct 15, 2009 Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Oct 07, 2009 Inspire Pharmaceuticals Down 8.6% Since SmarTrend's Sell Recommendation
 
ZACKS COMMENTARY FOR ISPH
Nov 09, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Inspire Pharmaceuticals, Inc., Sears Holdings, Moody's Corp., CBS Corporation and Forest Oil Corporation
Nov 09, 2009 Bull of the Day: Inspire Pharmaceuticals, Inc. (ISPH)
Nov 06, 2009 Zacks Equity Research: Report for ISPH
Aug 04, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Inspire Pharmaceuticals, Inc., Celanese, Vornado, Simon Property Group and Host Hotels
Aug 04, 2009 Bull of the Day: Inspire Pharmaceuticals (ISPH)
May 15, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Inspire Pharmaceuticals Inc., Allergan Inc., InSite Vision Incorporated, National Australia Bank Limited and Cypress Semiconductor.
May 14, 2009 Zacks Blog: Inspire Pharma Still Looking Good
Jan 12, 2009 Zacks Blog: Inspire Pharma's Inspiring Data

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research